Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Costa, LJ; Abbas, J; Hogan, KR; Kramer, C; McDonald, K; Butcher, CD; Littleton, A; Shoptaw, K; Kang, Y; Stuart, RK

Published Date

  • November 2012

Published In

Volume / Issue

  • 47 / 11

Start / End Page

  • 1403 - 1408

Published By

Electronic International Standard Serial Number (EISSN)

  • 1476-5365

International Standard Serial Number (ISSN)

  • 0268-3369

Digital Object Identifier (DOI)

  • 10.1038/bmt.2012.60

Language

  • en